VitaNova Life Sciences (VNOV) EBT Margin (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly EBT Margin came in at 5.99% in Q2 2026, down 6132.0% YoY from 0.1% in Q2 2025, and down 191.03% on a QoQ basis from 6.59% in Q1 2026.
VitaNova Life Sciences (VNOV) EBT Margin (2017 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has 7 years of EBT Margin data on file, last reported at 5.99% in Q2 2026.
- Quarterly EBT Margin fell 6132.0% year-over-year to 5.99% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 0.22% (down 4502.0% YoY) and the FY2026 annual result came in at 0.22%, down 4502.0% from the prior year.
- EBT Margin fell to 5.99% in Q2 2026, from 6.59% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 55.33% in Q2 2025 to a low of 245.77% in Q1 2023.
- A 5-year average of 15.88% and a median of 17.52% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2023 — EBT Margin tumbled 27549 bps — and 2024, when it surged 26856 bps.
- Tracing VNOV's EBT Margin over 5 years: stood at 26.01% in 2022, then sank by 662 bps to 146.17% in 2023, then surged by 114 bps to 20.8% in 2024, then climbed by 12 bps to 23.25% in 2025, then plunged by 126 bps to 5.99% in 2026.
- The last three EBT Margin figures came in at 5.99% (Q2 2026), 6.59% (Q1 2026), and 23.25% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.72 Bn | 95.55 Bn | 3.69 Bn | 1.24% |
| 2 | Cencora | 61.04 Bn | 58.23 Bn | 3.61 Bn | 1.18% |
| 3 | Cardinal Health | 54.28 Bn | 49.43 Bn | 2.56 Bn | 0.87% |
| 4 | Henry Schein | 10.07 Bn | 9.91 Bn | 1.10 Bn | 3.96% |
| 5 | Akso Health | 820.26 Mn | 820.04 Mn | - | - |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | -109.10% |
| 7 | Accendra Health | 98.17 Mn | 90.52 Mn | 263.41 Mn | -14.29% |
| 8 | 111 | 30.87 Mn | 109.39 Mn | 18.18 Mn | -1.14% |
| 9 | Cosmos Health | 13.28 Mn | 10.83 Mn | 1.51 Mn | -32.06% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -5.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -5.99% |
| Jan 31, 2026 | 6.59% |
| Oct 31, 2025 | 23.25% |
| Jul 31, 2025 | -31.22% |
| Apr 30, 2025 | 55.33% |
| Jan 31, 2025 | 35.11% |
| Oct 31, 2024 | 20.80% |
| Jul 31, 2024 | -41.87% |
| Apr 30, 2024 | 42.75% |
| Jan 31, 2024 | 22.79% |
| Apr 30, 2023 | -146.17% |
| Jan 31, 2023 | -245.77% |
| Oct 31, 2022 | 26.01% |
| Jul 31, 2022 | 14.23% |
| Apr 30, 2022 | -59.57% |
| Jan 31, 2022 | 29.72% |
| Oct 31, 2021 | 33.35% |
| Jul 31, 2017 | 116.47% |